AGP Executive Report

CBD for pets: Votum Labs’ SOS by Happy Pets launched a CBD calming spray for fireworks and travel, claiming THC-free formulas and non-sedating calm for anxious dogs and cats. Cannabis policy fight: North Carolina’s hemp-derived THC industry is getting squeezed as advocacy group CBHD pushes back on federal THC-threshold changes, with Winston-Salem feeling the impact. Hemp THC crackdown delay: Multiple reports point to federal hemp THC restrictions being paused, shifting the “ban” timeline and raising stakes for state regulators and retailers. Medical cannabis access model: Utah’s pharmacy-style medical cannabis program (pharmacist consults, cannabis-only dispensing) is being framed as a blueprint for a future Schedule III system. Health debate: A new study links cannabis use disorder with a higher lung cancer risk, reigniting the “smoke vs. evidence” argument. Enforcement headlines: Large cannabis seizures and arrests continue across the US and abroad, including a major haul near Yass and big interstate seizures. Road safety: Coroner findings in a fatal crash cite meth and also flag cannabis in the driver’s system. Texas legal risk: Delta-8 THC gummies may carry felony exposure in Texas as federal and state rules tighten around edible THC weight.

Hemp Policy Clash (US): A Virginia federal judge is being asked to slow a state law that effectively tightens hemp product sales by removing the old 25-to-1 CBD-to-THC ratio, with the lawsuit arguing it violates constitutional protections for hemp products sold across the state. Hemp THC Crackdown (US): Texas is facing fresh legal risk for delta-8 and other hemp-derived THC gummies after changes to how THC is classified and counted by total edible weight, with a single small gummy potentially triggering felony-level penalties. Medical Cannabis Retail Model (Utah): Utah’s medical cannabis pharmacies are being highlighted as a “pharmacy instead of dispensary” approach, requiring a licensed pharmacist to consult patients on dosing, delivery, and interactions. Hemp Advocacy (North Carolina): A North Carolina hemp coalition is pushing back on federal pressure that could reshape local rules, with Winston-Salem positioned as a key battleground for hemp-derived cannabinoid policy. Road Safety + Cannabis (NZ): A coroner found a meth-using driver’s crash was likely driven by speed, fatigue, emotional distress, and intoxication, while noting cannabis showed up in the other driver—raising concerns for lawmakers and road users. Cannabis Seizures (Global): Authorities report major cannabis busts, including a large I-80 seizure in Peru and multiple drug operations tied to “Indian hemp” in Nigeria.

Hemp THC court fight: A federal judge in Roanoke is being asked to slow Virginia’s hemp law after a lawsuit argues the state is effectively taking property without compensation, targeting hemp products sold through the “hemp channel” and the THC limits that were meant to keep them from getting too intoxicating. Cannabis in the spotlight: At the U.S. Open, Aryna Sabalenka briefly halted play after complaining about a strong weed smell, sparking a wave of online debate and jokes. CBD for pain shoppers: A UK retailer is promoting Kloris CBD Comfort Balm (800mg CBD per jar) with customer claims of reduced joint pain and improved mobility. Public health watch: Hong Kong health officials are investigating a confirmed mpox case and urging high-risk groups to get vaccinated, while customs also seized about 12kg of cannabis buds at the airport. Drug harm reminders: Idaho’s fentanyl case coverage highlights how overdose-related help can be treated harshly under state trafficking rules, underscoring the stakes around fentanyl risk.

Hemp THC policy shake-up: Congress approved a one-month delay of the federal hemp THC restrictions, keeping the industry in limbo while lawmakers debate whether regulation or prohibition is next. Regulatory enforcement: California moved to remove thousands of illegal hemp/kratom/7-OH products from store shelves, signaling tighter oversight. CBD for pain claims: A shopper praised a CBD Comfort Balm (800mg CBD plus CBG and plant butters) for helping severe joint pain and mobility. Cannabis and driving risk: An Elgin woman was convicted after testing showed THC levels about seven times the legal limit while driving with her teenage son. Public health & outbreaks: Hong Kong is investigating a confirmed mpox case and urged high-risk groups to get vaccinated. Drug harms spotlight: A Utah man was sentenced to 12+ years for distributing fentanyl that led to a death, underscoring ongoing overdose risks. Sports culture moment: Aryna Sabalenka paused a US Open match after complaining about a strong weed smell in the stands.

Hemp THC policy shake-up: The U.S. House passed a short-term funding bill that pushes the federal hemp THC restrictions back about a month, giving the industry a brief reprieve while lawmakers scramble over what comes next. Public health & enforcement: Hong Kong’s CHP is investigating a confirmed mpox case and urging high-risk groups to get vaccinated, while Hong Kong Customs seized about 12kg of cannabis buds at the airport and arrested three passengers. Cannabis in the spotlight (sports): Aryna Sabalenka briefly halted her U.S. Open match after complaining about a strong weed smell in the stands, sparking a wave of online reactions. Local harm-reduction debate: Quincy, Massachusetts-area officials discussed banning kratom sales after poison-control and death concerns, highlighting how “natural” products can still pose serious risks. Legal system pressure: Nigeria’s Jos University Teaching Hospital reported psychiatric bed shortages as mental health demand rises, with families waiting in emergency units. Court & custody headlines: A Wyoming driver was convicted after testing seven times over the legal cannabis limit while her son was in the car.

Hemp THC Policy: Lawmakers are debating how to regulate hemp-derived THC products after Trump signed a bill delaying the federal recriminalization deadline from November 12 to December 11, with some pushing alcohol-style rules and others still aiming for a full ban. Criminal Justice & Cannabis: Former Alabama player Darius Miles faces new jail-related charges after staff allegedly found “paper route” synthetic marijuana in his property while he awaits trial for a 2023 capital murder case. Public Safety & Kratom: Quincy, Nebraska-area officials discussed a possible kratom sales ban over health concerns, while a Bucks County judge barred a smoke shop from selling kratom to minors under 21. Tech & Identity Risk: FBI probes a dark-web ID verification breach after millions of driver’s license scans were reportedly sold, including medical-record-type data that could impact cannabis businesses. Health Research: An Oregon state-regulated psilocybin study linked supervised sessions to lower depression, anxiety, and PTSD with no serious adverse events. Cannabis in the Courts: A clemency move commuted federal marijuana sentences for two people as rescheduling advances. Drug Enforcement: Bridgeport raid reportedly seized fentanyl pills plus other drugs, including marijuana, and police expect more arrests.

Hemp THC Policy: Congress just approved a one-month delay of most federal hemp-derived THC restrictions, pushing the effective date from Nov. 12, 2026 to Dec. 11, 2026—while synthetic cannabinoids still face the original timeline. Regulatory Safety: Missouri regulators issued a recall for certain marijuana products made via chemical modification/conversion/synthetic derivation of cannabinoids, urging consumers to stop use and report adverse reactions. Product Liability/Enforcement: Colorado’s system is under fire after reports of a marijuana sleep aid causing liver injuries sat on shelves for over a year before formal safety warnings—highlighting slow consumer protection. Driving & Public Safety: A new study warns edible THC can impair driving performance even when blood THC stays below typical roadside legal cutoffs. Local Cannabis Market: Missouri also saw a DCR recall notice, while Minnesota opened a new dispensary in Steele County. Health Research: Studies linked trauma-related psychiatric disorders to higher later heart and stroke risk, and perimenopause research explored depression/cognitive signals using metabolic indices. Cannabis in the News Cycle: A judge issued an arrest warrant in a UK cannabis case, and separate reports covered marijuana seizures and enforcement actions.

Hemp THC policy pause: Congress and the White House moved to delay the federal hemp THC product ban, pushing key restrictions to Dec. 11 (from Nov. 12) and giving businesses a short runway to adjust instead of facing an immediate crackdown. Driving safety: A new study flags edible THC as a hidden road risk—drivers can show impaired lane control and slower reactions even when roadside blood tests stay under the usual legal cutoff. Sleep & CBD research: A clinical review reports cannabinoids may improve insomnia—faster sleep onset, longer duration, and better sleep continuity—with mostly mild, temporary side effects. Local cannabis access: Steele County, Minn. welcomed its first cannabis dispensary, Black Bear Dispensary, as owners aim to reduce stigma and serve local demand. Community health & policy: Virginia’s cannabis rollout is moving through local special-use permitting, with municipalities limited by state mandate as sales are slated for July 1, 2027. Public health enforcement: Nigeria Customs handed over billions in seized drugs, including synthetic cannabis, to NDLEA and environmental regulators.

Hemp THC policy shift: Congress approved a one-month delay of the federal ban on hemp THC products, buying time for regulators and businesses while the legal fight continues. Medical cannabis access: Illinois added PMOS (formerly PCOS) with chronic pain and sickle cell disease to its Medical Cannabis Patient Program, expanding qualifying conditions for patients. Product safety & enforcement: California’s Newsom announced the removal of nearly 15,300 illegal hemp, kratom, and 7-OH products from store shelves, signaling continued crackdown on questionable consumer goods. Research watch: A lab study reported ultra-low THC kept breast cancer cells in a less aggressive state, adding to the growing (and still debated) science around cannabinoids and cancer behavior. Industry spotlight: A Massachusetts-style hemp-derived THC entrepreneur (Lenox native) is lobbying Congress to protect low-dose hemp-derived THC products as federal rules get rewritten. Public health angle: A study highlighted that regular cannabis users may see higher stress hormone levels after waking, adding fuel to the ongoing discussion about long-term effects. Clinical note: A viewpoint argues GLP-1–targeted therapies could influence craving and substance use disorders, linking obesity/diabetes drug science to addiction research.

FDA Recall Alert (CBD): Lexia LLC is recalling Broadway Joe’s Pain Cream after the FDA flagged “potential contamination of raw material,” affecting 3,600 jars sold in Colorado (lot/UPC details provided). Cannabis & Cancer Research: A lab study reports ultra-low THC exposure may keep breast cancer cells in a less aggressive, less invasive state, pointing to CB2R involvement. Dementia Care Trial: A Phase 2 trial suggests a THC-CBD treatment could reduce agitation in advanced dementia patients, with much higher improvement rates than placebo—though it’s not the same as retail cannabis. Anxiety & CBD Review: A new evidence roundup revisits what cannabidiol may do for anxiety, while stressing that lab findings don’t automatically translate to reliable human treatment. CHS ER Spike: CDC data shows 199,565 emergency visits tied to cannabis hyperemesis syndrome from Jan 2023–May 2026, with a jump after a new diagnostic code in Oct 2025. Policy Watch: California says it removed thousands of illegal hemp/kratom/7-OH products from shelves, while Naperville, Illinois approved a retail kratom ban starting Oct 1. Industry/Access: cbdMD announced a deal to acquire Twinlab Brands, expanding into supplements and wellness. Veterans: A VA records op-ed argues “cannabis use disorder” diagnoses may be entered without meaningful consideration of authorized use. Summer Use Habits: A survey finds half of medical cannabis users still prefer flower/smoking in hot weather, with vapes and edibles trailing.

Hemp Policy: Congress just passed a one-month delay of the federal hemp-derived THC ban, pushing it to Dec. 11—giving Minnesota’s THC beverage and edible makers a short runway while lawmakers try to build a real regulatory framework. Corporate Moves: cbdMD signed a definitive deal to acquire Twinlab brands (including Reserveage, Metabolife, and Alvita Tea), aiming to expand beyond hemp into legacy supplements, sports nutrition, women’s beauty, weight loss, and longevity. Medical Cannabis & Safety: Ontario suspended a ketamine-prescribing doctor for asking patients to sign away their right to sue or complain—raising red flags about patient consent and professional oversight. Drug Law Watch: North Dakota lawmakers face renewed pressure to ban kratom after officials cited rising deaths and poison control calls, while Iowa also warns of kratom’s opioid-like risks. Research & Health: A small study suggests home HEPA air purifiers may improve brain executive function after a month, tying cleaner indoor air to cognitive performance. Clinical Pipeline: SciSparc’s NeuroThera is pursuing FDA orphan drug designation for an adult Tourette syndrome candidate, backed by a government affairs firm.

DEA Marijuana Rescheduling Hearing: The DEA and seven opposing groups spar over whether marijuana should move from Schedule I to Schedule III, with the judge pushing hard on what “marijuana” even means and which medical-use test should apply. Hemp THC Policy: The U.S. House passed a bill to delay the federal hemp THC product ban to Dec. 11, sending it to Trump’s desk, while GOP lawmakers protested the delay. Kratom Crackdown: Iowa officials warn of rising kratom deaths and poison control calls, as Minnesota counties weigh regulation and the DEA moves certain kratom-related compounds to Schedule I. CBD/Anxiety Research: A new explainer reviews what evidence says about cannabidiol for anxiety, noting promising signals but limited human certainty. Public Health & Safety: A study finds kids’ accidental recreational drug ingestions spiked over 25 years, with cannabinoids driving much of the rise. Dementia Risk Update: WHO added seven new dementia risk factors, including sleep problems and HIV, to its updated guidance.

Regulation & Retail Shockwave: Michigan regulators suspended a hemp business license after finding delta-9 THC above the 0.3% legal threshold, including very high-potency concentrates and two topical patches, signaling tighter enforcement for THC-adjacent products. Federal Policy Pressure: A federal law change is leaving local hemp retailers facing an uncertain future, with one Illinois shop saying 95% of its products could become illegal after Nov. 12. Medical Pipeline: MIRA Pharmaceuticals posted positive 7-day dose-range tox results for its oral, non-opioid inflammatory pain candidate MIRA-55, moving its IND-enabling work forward. Cannabis & Health Debate: A large study linked recreational drug use to higher stroke risk, with cannabis tied to a 37% increase—especially notable in younger adults. Public Safety & Community: International Overdose Awareness Day events in Gainesville and Carriere highlighted overdose prevention and recovery resources, including messaging that fentanyl-laced pills and risky substance use can affect anyone. Courtroom Update: Yung Filly pleaded guilty to cannabis possession in Australia and was fined, as his rape retrial timeline continues. Industry Watch (AU): ASX cannabis names like Neurotech, Vitura Health, and Cann Group drew attention for progress tied to trials, telehealth prescribing, and licensed capacity.

DEA Rescheduling Fight: After 11 days of hearings, the DEA is arguing marijuana should move from Schedule I to Schedule III, while seven groups push back—so the “medical-use test” question could decide the outcome. Hemp THC Delay Push: The U.S. House is set to vote on delaying the federal hemp THC product ban (currently slated for November) to Dec. 11, giving lawmakers more time to craft rules. Medical Cannabis Access: A federally funded cancer study of 65 patients found symptom relief varies by THC/CBD mix, and researchers say insurance coverage is still a major barrier. Breastmilk & Cannabis: A new review says only two human studies exist on cannabis use and breastmilk nutrients/immune components, so diet and social factors may be driving differences. CBD for Pets: A vet warns dog CBD claims outpace research and FDA-style safety testing, urging caution with over-the-counter products. Work Absenteeism: A new study links medical cannabis access to fewer health-related missed workdays (about 7%), especially in physically demanding jobs. Regulatory/Trial Update: SciSparc’s NeuroThera partner says enrollment is progressing for a CBD-based autism trial (SCI-210). Enforcement Headlines: Police seized 22kg of suspected cannabis in Welland, and Barbados eradicated nearly 6,000 marijuana plants in St John.

Synthetic cannabinoid crackdown: Oneida County moved to tighten rules on synthetic cannabinoids, requiring clearer labeling of what’s actually in “K2/Spice/Deuce” products sold in smoke shops, after earlier local action on kratom. Public health warning on vapes: Ireland’s HSE-linked testing found high-risk cannabinoids in vape products, with officials urging stronger regulation and better public awareness beyond “nicotine” assumptions. Kids poisoned by THC/CBD candies: Two brothers in Jerusalem were hospitalized after eating THC/CBD cannabis candies (20mg THC/10mg CBD each), with clinicians noting the smaller child showed worse effects. Cannabis and community safety: Tenants in Rayleigh, UK, say they’re facing intimidation and assaults tied to cannabis use, alleging poor response from housing managers. Cannabis stocks watch: Australia’s Neurotech (ASX:NTI) drew attention as a cannabinoid drug-development play focused on pediatric autism trials, while Cann Group (ASX:CAN) and Little Green Pharma (ASX:LGP) remained in the spotlight for execution and export-driven strategy. Drug enforcement roundup: Nigeria’s NDLEA reported a major Lagos airport haul—captagon (“Jihadi drug”) and millions of opioid tablets—plus separate seizures tied to international routes. Telehealth weight-loss concern: Australia’s ABC reports experts calling for tighter oversight after a telehealth clinic prescribed GLP-1 injectable weight-loss meds to a patient with a history of anorexia nervosa.

Drug Enforcement: Nigeria’s NDLEA says it seized over ₦6.2bn in drugs at Lagos’ Murtala Muhammed International Airport, including 47,200 Captagon (“Jihadi drug”) pills hidden inside Ghanaian “Ghana Soap,” plus 3.9 million opioid tablets (Tramaking/Tapentadol) from abandoned consignments, after arresting a 49-year-old cross-border kingpin arriving from Accra. Cannabinoid Policy & Markets: A Wisconsin hemp shop owner says his arrest over alleged illegal THC products was racially motivated, arguing his delta-9 THC sales stayed under the 0.3% limit and that customers used the products for pain and sleep. Medical Cannabis & Research: New Mexico opened medical psilocybin producer permit applications, aiming to grow mushrooms for controlled therapeutic use for conditions like treatment-resistant depression and PTSD. Health & Lifestyle: A study on NYC seniors reports most older adults use marijuana mainly “to get high,” not for medical reasons. Agriculture & Soil: Regenerative growers may use occasional strategic tillage, with a meta-analysis suggesting any negative soil impacts tend to fade within about six months.